Ain shams university
Cairo, Cairo Governorate, 11111, Egypt
Location status: Recruiting
NCT Number: NCT07761845
The aim of this study is to evaluate the prognostic utility of the red cell distribution width/albumin ratio (RAR), measured within 24 hours of hospital admission, in predicting 30-day mortality among patients with burn injuries.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Cairo, Cairo Governorate, 11111, Egypt
Location status: Recruiting
The aim of this study is to evaluate the prognostic utility of the red cell distribution width/albumin ratio (RAR), measured within 24 hours of hospital admission, in predicting 30-day mortality among patients with burn injuries.
Patients presenting with acute thermal injuries will be screened based on inclusion/exclusion criteria.
After consent, Patients' characteristics (age, sex, weight), clinical parameters (Total burn surface area, Abbreviated burn severity index), and comorbidities will be recorded.
Laboratory and calculation:
On admission to ED, an arterial blood gas (ABG) sample will be collected to calculate base deficit (BD) and lactate level.
Simultaneously, venous blood will be drawn for C-reactive protein (CRP) and serum albumin, CBC, serum urea, creatinine, AST, ALT, and electrolyte's (NA+, K+, MG+) estimation.
Red Cell Distribution Width/Albumin will be calculated: as ((RDW (Standard Deviation of Red Blood Cell Volume / Mean Corpuscular Volume) × 100%.) / albumin (g/L) ))from admission labs .
Serial: Lactate/Base Defecit at 6hr, 12hr, 24hr as a monitor for proper resuscitation Calculation of Severity Scores
Both scores will be calculated on admission and compared with admission (RDW/albumin)ratio to assess relative and incremental predictive value for 30-day mortality.
Supportive care:
3 - Post-Resuscitation and Definitive Management Protocol (After 72 h) Hemodynamic stabilization (post-resuscitation phase) Transition from resuscitation fluids to maintenance fluids. Avoid "fluid creep" (excess positive balance leading to pulmonary edema, abdominal compartment). → cautious use of diuretics to mobilize edema.
Maintain: MAP ≥65 mmHg, urine output ≥0.5 mL/kg/h. Ongoing ventilatory support if required; lung-protective strategy for ARDS. Weaning as early as possible.
Infection prevention and sepsis monitoring
Wound care and surgical management
Rehabilitation and functional recovery • Early physiotherapy, occupational therapy for daily living skills and Psychosocial support for patient and family.
Criteria for transfer to ward • Hemodynamically stable, off vasopressors.
Primary outcome:
To determine the correlation between Red Cell Distribution Width/Albumin on admission and 30 days hospital mortality in burn patients.
Secondary outcomes:
To determine the correlation between Red Cell Distribution Width/Albumin with :
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days
To determine the correlation between Red Cell Distribution Width/Albumin on admission and 30 days hospital mortality in burn patients.
Time frame: 30 days
To determine the correlation between Red Cell Distribution Width/Albumin with o ICU length of stay
Time frame: 30 days
To compare RDW/albumin ratio with R-Baux score as a predictor of mortality in burn patient.
Time frame: 30 days
To determine the correlation between Red Cell Distribution Width/Albumin with
o Requirements of inotropes or vasopressors
Time frame: 30 days
To determine the correlation between Red Cell Distribution Width/Albumin with
o Duration of mechanical ventilation
Contact information is provided by the study sponsor or research team.
Ahlam M abdelnaby. study principal investigator, MBBCH, MSc .
CONTACT
Sara H Saleh, MD
CONTACT
Ain Shams University
Other
Measurement of Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for 30-day Mortality of Patients With Burn Injuries
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06745557
Burns, Cicatrix
Beverwijk, Netherlands
View Trial DetailsNCT02350205
Burns, Wounds and Injuries
Calgary, Alberta, Canada
View Trial DetailsNCT06857435
Burns, Contracture Scar
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06857448
Burns, Contracture Scar
Pittsburgh, Pennsylvania, United States
View Trial Details